Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
INCY | INCYTE CORP | United States | $11.60B | 224,526,128 | 79.30% | 20.70% | Net Selling | Net Buying |
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.66B | 56,769,081 | 61.03% | 38.97% | Net Selling | Net Selling |
SMLR | SEMLER SCIENTIFIC INC | United States | $183.58M | 7,031,083 | 40.20% | 59.80% | Net Buying | |
VYGR | VOYAGER THERAPEUTICS INC | United States | $413.77M | 54,300,627 | 47.14% | 52.86% | Net Selling | Net Selling |
INMD | INMODE LTD | Israel | $1.44B | 83,982,462 | 62.26% | 0.00% | ||
NBIX | NEUROCRINE BIOSCIENCES INC | United States | $13.53B | 99,507,490 | 69.67% | 30.33% | Net Selling | Net Selling |
PGNY | PROGYNY INC | United States | $3.09B | 96,499,402 | 73.38% | 26.62% | Net Selling | Net Selling |
AMLX | AMYLYX PHARMACEUTICALS INC | United States | $119.30M | 67,782,139 | 52.42% | 47.58% | Net Buying | Net Selling |
UTHR | UNITED THERAPEUTICS CORP | United States | $11.00B | 47,058,545 | 87.59% | 12.41% | Net Selling | Net Selling |
CCRN | CROSS COUNTRY HEALTHCARE INC | United States | $595.20M | 34,725,677 | 83.53% | 16.47% | Net Selling | Net Selling |
GILD | GILEAD SCIENCES INC | United States | $81.50B | 1,245,774,616 | 83.54% | 1.09% | Net Selling | Net Selling |
EXEL | EXELIXIS INC | United States | $7.19B | 303,194,259 | 85.28% | 4.07% | Net Selling | Net Buying |
CORT | CORCEPT THERAPEUTICS INC | United States | $2.36B | 103,517,388 | 30.65% | 69.35% | Net Buying | Net Buying |
BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $15.36B | 189,879,803 | 97.46% | 1.62% | Net Selling | Net Selling |
JNJ | JOHNSON & JOHNSON | United States | $352.02B | 2,408,767,228 | 69.52% | 0.19% | Net Selling | Net Selling |
OSUR | ORASURE TECHNOLOGIES INC | United States | $392.60M | 73,796,268 | 91.59% | 8.41% | Net Selling | Net Selling |
SDGR | SCHRODINGER INC | United States | $1.73B | 72,310,612 | 77.41% | 22.59% | Net Selling | Net Selling |
PCRX | PACIRA BIOSCIENCES INC | United States | $1.22B | 46,500,778 | 68.56% | 31.44% | Net Selling | Net Selling |
SIGA | SIGA TECHNOLOGIES INC | United States | $624.90M | 71,091,616 | 35.56% | 64.44% | Net Selling | Net Selling |
PBYI | PUMA BIOTECHNOLOGY INC | United States | $242.00M | 48,207,162 | 55.20% | 44.43% | Net Selling | |
KMDA | KAMADA LTD | Israel | $296.02M | 57,479,528 | 10.06% | 0.00% | ||
AMPH | AMPHASTAR PHARMACEUTICALS INC | United States | $1.98B | 48,095,862 | 49.07% | 50.93% | Net Selling | Net Buying |
CNC | CENTENE CORP | United States | $39.49B | 533,656,000 | 93.84% | 3.11% | Net Selling | Net Selling |
TCMD | TACTILE SYSTEMS TECHNOLOGY INC | United States | $337.49M | 23,600,584 | 76.27% | 23.73% | Net Selling | Net Selling |
MOH | MOLINA HEALTHCARE INC | United States | $20.05B | 58,600,000 | 79.70% | 20.30% | Net Buying | Net Buying |
HALO | HALOZYME THERAPEUTICS INC | United States | $4.89B | 126,824,800 | 78.23% | 21.77% | Net Selling | Net Selling |
ADUS | ADDUS HOMECARE CORP | United States | $1.53B | 16,227,251 | 33.44% | 66.56% | Net Selling | Net Selling |
HCM | HUTCHMED (CHINA) LTD | Hong Kong | $3.16B | 871,256,270 | 1.76% | 0.00% | ||
VMD | VIEMED HEALTHCARE INC | United States | $322.07M | 38,756,636 | 59.68% | 12.53% | Net Selling | |
DOCS | DOXIMITY INC | United States | $4.44B | 186,553,750 | 49.68% | 11.38% | Net Selling | Net Selling |
RPRX | ROYALTY PHARMA PLC | United States | $16.73B | 597,434,791 | 51.02% | 16.51% | Net Selling | Net Buying |
ASTH | ASTRANA HEALTH INC | United States | $2.04B | 55,423,408 | 14.42% | 85.58% | Net Selling | Net Selling |
MDT | MEDTRONIC PLC | Ireland | $105.88B | 1,327,822,539 | 82.10% | 0.53% | Net Selling | Net Selling |
MCK | MCKESSON CORP | United States | $71.39B | 131,408,286 | 85.09% | 11.48% | Net Selling | Net Selling |
CHE | CHEMED CORP | United States | $8.47B | 15,117,093 | 95.25% | 4.15% | Net Selling | Net Buying |
EW | EDWARDS LIFESCIENCES CORP | United States | $51.94B | 601,000,000 | 79.55% | 1.16% | Net Selling | Net Buying |
TGTX | TG THERAPEUTICS INC | United States | $2.08B | 154,420,772 | 53.78% | 46.22% | Net Selling | Net Selling |
NSYS | NORTECH SYSTEMS INC | United States | $47.43M | 2,740,178 | 1.76% | 98.24% | Net Buying | |
ROIV | ROIVANT SCIENCES LTD | Bermuda | $8.89B | 805,846,006 | 40.14% | 59.86% | Net Selling | Net Selling |
COLL | COLLEGIUM PHARMACEUTICAL INC | United States | $1.16B | 31,959,828 | 58.62% | 41.38% | Net Selling | Net Selling |
STAA | STAAR SURGICAL CO | United States | $2.29B | 48,865,875 | 63.00% | 37.00% | Net Buying | Net Buying |
AZN | ASTRAZENECA PLC | United Kingdom | $233.05B | 1,550,162,626 | 31.49% | 0.00% | ||
CVS | CVS HEALTH CORP | United States | $84.54B | 1,258,449,553 | 80.69% | 0.61% | Net Selling | Net Selling |
LNTH | LANTHEUS HOLDINGS INC | United States | $4.49B | 68,525,556 | 53.56% | 46.44% | Net Selling | Net Selling |
GMAB | GENMAB A | Denmark | $18.60B | 66,074,535 | 70.53% | 0.00% | ||
UTMD | UTAH MEDICAL PRODUCTS INC | United States | $236.59M | 3,589,014 | 64.94% | 35.06% | Net Selling | |
DCGO | DOCGO INC | United States | $376.06M | 104,171,369 | 55.45% | 21.45% | Net Selling | Net Buying |
SEM | SELECT MEDICAL HOLDINGS CORP | United States | $3.52B | 128,361,492 | 7.34% | 92.66% | Net Selling | Net Selling |
HOLX | HOLOGIC INC | United States | $17.83B | 234,731,521 | 86.75% | 13.25% | Net Selling | Net Selling |
SLP | SIMULATIONS PLUS INC | United States | $893.13M | 19,984,945 | 58.57% | 41.43% | Net Selling | Net Selling |
COR | CENCORA INC | United States | $48.05B | 199,481,993 | 80.49% | 19.51% | Net Selling | Net Selling |
WST | WEST PHARMACEUTICAL SERVICES INC | United States | $26.25B | 72,843,157 | 94.34% | 3.67% | Net Buying | Net Buying |
HUM | HUMANA INC | United States | $36.86B | 120,500,635 | 92.06% | 2.18% | Net Selling | Net Selling |
MEIP | MEI PHARMA INC | United States | $20.32M | 6,662,857 | 17.91% | 82.09% | Net Buying | |
VEEV | VEEVA SYSTEMS INC | United States | $32.41B | 161,316,597 | 78.97% | 11.64% | Net Selling | Net Selling |
DXCM | DEXCOM INC | United States | $49.45B | 397,683,837 | 94.73% | 4.43% | Net Selling | Net Selling |
CAH | CARDINAL HEALTH INC | United States | $25.10B | 243,233,153 | 87.14% | 4.07% | Net Selling | Net Selling |
SNY | SANOFI | France | $124.28B | 1,264,799,969 | 19.51% | 0.00% | ||
ICLR | ICON PLC | Ireland | $25.49B | 82,683,805 | 95.42% | 0.00% | ||
ALC | ALCON INC | United States | $38.85B | 493,244,479 | 47.85% | 0.00% | ||
MDXG | MIMEDX GROUP INC | United States | $921.43M | 146,958,420 | 42.42% | 57.58% | Net Buying | Net Selling |
PODD | INSULET CORP | United States | $11.62B | 69,925,730 | 80.09% | 19.91% | Net Selling | Net Selling |
LMAT | LEMAITRE VASCULAR INC | United States | $1.46B | 22,337,216 | 73.96% | 26.04% | Net Selling | Net Selling |
AMN | AMN HEALTHCARE SERVICES INC | United States | $2.16B | 37,888,539 | 90.98% | 9.02% | Net Selling | Net Buying |
TALK | TALKSPACE INC | United States | $526.98M | 168,903,571 | 48.64% | 32.30% | Net Buying | Net Buying |
ABT | ABBOTT LABORATORIES | United States | $186.58B | 1,735,184,289 | 75.12% | 1.14% | Net Selling | Net Selling |
GSK | GSK PLC | United Kingdom | $83.37B | 4,056,000,000 | 7.26% | 0.00% | ||
ISRG | INTUITIVE SURGICAL INC | United States | $133.13B | 354,705,822 | 83.49% | 0.81% | Net Buying | Net Buying |
GMED | GLOBUS MEDICAL INC | United States | $6.84B | 135,372,391 | 77.48% | 22.52% | Net Selling | Net Selling |
UNH | UNITEDHEALTH GROUP INC | United States | $456.68B | 921,934,109 | 87.85% | 2.03% | Net Selling | Net Selling |
IRMD | IRADIMED CORP | United States | $530.07M | 12,662,809 | 51.01% | 41.22% | Net Selling | |
ZBH | ZIMMER BIOMET HOLDINGS INC | United States | $24.48B | 205,084,022 | 74.93% | 25.07% | Net Selling | Net Selling |
THC | TENET HEALTHCARE CORP | United States | $9.61B | 99,995,000 | 34.38% | 65.62% | Net Selling | Net Selling |
BRKR | BRUKER CORP | United States | $11.15B | 137,671,143 | 49.25% | 50.75% | Net Selling | Net Selling |
STE | STERIS PLC | Ireland | $20.15B | 98,814,035 | 95.00% | 0.91% | Net Selling | |
ALGN | ALIGN TECHNOLOGY INC | United States | $23.21B | 75,104,132 | 84.67% | 15.33% | Net Selling | Net Selling |
BNTX | BIONTECH SE | Germany | $20.73B | 237,725,735 | 17.05% | 0.00% | ||
CI | CIGNA GROUP | United States | $103.63B | 292,355,022 | 87.03% | 1.49% | Net Selling | Net Selling |
FONR | FONAR CORP | United States | $109.18M | 6,710,807 | 47.70% | 3.51% | ||
BIIB | BIOGEN INC | United States | $30.42B | 145,596,895 | 87.72% | 2.11% | Net Selling | Net Selling |
KIDS | ORTHOPEDIATRICS CORP | United States | $712.61M | 23,549,496 | 43.14% | 56.86% | Net Selling | Net Selling |
NVS | NOVARTIS AG | Switzerland | $198.82B | 2,040,400,000 | 6.93% | 0.00% | ||
PEN | PENUMBRA INC | United States | $7.91B | 38,703,659 | 88.87% | 11.04% | Net Selling | Net Selling |
TFX | TELEFLEX INC | United States | $9.73B | 47,056,482 | 95.84% | 2.71% | Net Selling | Net Selling |
VNDA | VANDA PHARMACEUTICALS INC | United States | $265.82M | 57,537,499 | 56.23% | 43.77% | Net Selling | Net Selling |
STRR | STAR EQUITY HOLDINGS INC | United States | $14.26M | 15,848,202 | 3.66% | 96.34% | Net Buying | Net Selling |
REGN | REGENERON PHARMACEUTICALS INC | United States | $96.94B | 109,761,896 | 69.39% | 30.61% | Net Selling | Net Buying |
PRVA | PRIVIA HEALTH GROUP INC | United States | $2.17B | 118,568,826 | 43.55% | 56.45% | Net Selling | Net Selling |
ZTS | ZOETIS INC | United States | $72.54B | 457,867,115 | 92.81% | 5.62% | Net Selling | Net Selling |
BTMD | BIOTE CORP | United States | $411.41M | 74,531,558 | 17.03% | 44.56% | Net Selling | |
ATR | APTARGROUP INC | United States | $9.50B | 66,263,631 | 89.89% | 3.62% | Net Selling | Net Selling |
DBVT | DBV TECHNOLOGIES SA | France | $131.53M | 96,431,770 | 39.10% | 15.37% | Net Buying | Net Buying |
OPCH | OPTION CARE HEALTH INC | United States | $5.15B | 173,816,267 | 12.08% | 87.92% | Net Selling | Net Selling |
QTRX | QUANTERIX CORP | United States | $592.27M | 38,063,618 | 63.63% | 36.37% | Net Buying | Net Selling |
PLX | PROTALIX BIOTHERAPEUTICS INC | Israel | $84.01M | 73,052,124 | 6.75% | 93.25% | Net Buying | |
RVTY | REVVITY INC | United States | $12.54B | 123,529,821 | 86.51% | 2.53% | Net Buying | Net Buying |
DVA | DAVITA INC | United States | $11.71B | 87,700,000 | 14.23% | 85.77% | Net Buying | Net Buying |
PINC | PREMIER INC | United States | $2.51B | 119,817,876 | 74.36% | 2.23% | Net Selling | |
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | United States | $11.76B | 51,349,770 | 96.79% | 3.21% | Net Selling | Net Selling |
RMD | RESMED INC | United States | $32.03B | 146,907,207 | 54.56% | 4.31% | Net Selling | Net Selling |
Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
682 | +1.20% | +1.13% | -9.62% | -22.18% | 14.88x | 5.85x | -68.98% | +2.75% | +21.30% | +91.76% | Strong Buy | ||
66 | +0.75% | +4.09% | -5.10% | -0.74% | 38.49x | 4.18x | -21.75% | +6.53% | +11.20% | +10.85% | Buy | ||
17 | +0.34% | +1.38% | -4.08% | +12.78% | 159.81x | 6.13x | +32.60% | +7.65% | +14.35% | +16.05% | Buy | ||
90 | +0.98% | +2.24% | -2.72% | -6.94% | 33.92x | 2.09x | +11.56% | +2.78% | +5.22% | +37.77% | Strong Buy | ||
12 | -0.85% | -2.11% | -4.78% | +3.59% | 18.86x | 2.91x | +20.02% | +6.15% | +14.19% | +16.44% | Buy | ||
61 | +0.87% | +0.45% | -8.40% | -24.77% | 72.49x | 3.38x | +6.61% | +2.33% | +5.91% | +38.22% | Buy | ||
50 | -0.63% | -0.25% | -6.53% | +3.06% | -1.17x | 4.49x | -87.35% | +6.17% | +13.08% | +19.34% | Buy | ||
154 | +0.28% | +1.14% | -4.31% | -15.96% | 28.63x | 3.70x | +10.75% | +5.35% | +7.78% | +22.84% | Buy | ||
9 | +0.52% | +1.70% | -0.69% | +37.51% | 26.24x | 147.94x | +18.14% | +3.52% | +19.64% | +3.58% | Buy | ||
56 | +1.23% | +1.70% | -4.37% | -11.53% | 48.29x | 3.53x | +11.70% | +7.83% | +10.36% | +20.52% | Buy |